FDC116115: A prospective study of sexual function in sexually active men treated for BPH
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2018
At a glance
- Drugs Dutasteride/tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 13 Oct 2018 Results of a post-hoc analysis published in the International Journal of Clinical Practice.
- 16 Oct 2017 Primary endpoint of total MSHQ scores at month 12 has been met, according to results published in the BJU International.
- 16 Oct 2017 Results published in the BJU International